SCHEMBL4650382

SCHEMBL4650382

CC(=O)c1cc(Cl)c(C)cc1OCC(=O)Nc1ccccc1C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTDSP1 Q9GZU7 1/20 0.61
▸ NOD2 Q9HC29 1/20 0.61
▸ HCAR2 Q8TDS4 3/20 0.56
▸ MEN1 O00255 5/20 0.55
▸ KMT2A Q03164 5/20 0.55
▸ CASP3 P42574 1/20 0.55
▸ SENP8 Q96LD8 1/20 0.55
▸ SENP7 Q9BQF6 1/20 0.55
▸ SENP6 Q9GZR1 1/20 0.55
▸ TRPM4 Q8TD43 4/20 0.55
▸ ALDH1A1 P00352 4/20 0.53
▸ MAPT P10636 2/20 0.53
▸ GBA1 P04062 1/20 0.53
▸ HTT P42858 1/20 0.53
▸ KDM4E B2RXH2 3/20 0.52
▸ POLB P06746 3/20 0.51
▸ G6PD P11413 1/20 0.51
▸ NPC1 O15118 2/20 0.50
▸ RAB9A P51151 2/20 0.50
▸ HSD17B10 Q99714 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4649782 0.91 HCAR2 (0.60) CTDSP1NOD2HCAR2MEN1KMT2A
SCHEMBL4651116 0.88 CTDSP1 (0.55) CTDSP1NOD2HCAR2MEN1KMT2A
SCHEMBL4912699 0.87 CTDSP1 (0.61) CTDSP1NOD2HCAR2MEN1KMT2A
SCHEMBL4650465 0.87 HCAR2 (0.56) CTDSP1NOD2HCAR2MEN1KMT2A
SCHEMBL4650577 0.87 HCAR2 (0.56) CTDSP1NOD2HCAR2MEN1KMT2A
SCHEMBL4905864 0.86 CTDSP1 (0.66) CTDSP1NOD2HCAR2MEN1KMT2A
SCHEMBL4650386 0.84 POLB (0.64) CTDSP1NOD2HCAR2MEN1KMT2A
SCHEMBL4649772 0.84 TRPM4 (0.66) CTDSP1NOD2HCAR2MEN1KMT2A
SCHEMBL4650476 0.83 HCAR2 (0.59) CTDSP1NOD2HCAR2MEN1KMT2A
SCHEMBL4651371 0.83 HCAR2 (0.66) CTDSP1NOD2HCAR2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101336236-A Anthranilic acid derivatives useful in treating infection with hepatitis c virus WYETH CORP (US) 2008-12-31 — — CN claimed
EP-1966181-A2 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS Wyeth (US) 2008-09-10 — — EP claimed
WO-2008051244-A2 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS WYETH (US) 2008-05-02 — — WO claimed
EP-1966181-A2 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS Wyeth (US) 2008-09-10 — — EP disclosed
WO-2008051244-A2 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS WYETH (US) 2008-05-02 — — WO disclosed
Send feedback